801/2682US=32 / Gastro
Dai M, Gonzalez L, Fong Y. Viral-based therapies for primary and secondary liver cancer. In: Clavien PA, Breitenstein S. Malignant liver tumors: current and emerging therapies. 3ª ed. New Jersey: John Wiley & Sons, 2010. p. 352-67. ISBN 978-1-4051-7976-8.

CANCER DE FIGADO; TRATAMENTO VIRAL; VETORES VIRAIS; TERAPIA GENICA; TERAPIA ONCOLOGICA; RETROVIRUS; REOVIRUS; VACINA; DOENCA DE NEWCASTLE; ADENOVIRUS; HERPES SIMPLES (HSV-1)


802/2682US=32 / Gastro
Villanueva A, Alsinet C, Llovet JM. Signaling pathways and rationale for molecular therapies in hepatocellular carcinoma. In: Clavien PA, Breitenstein S. Malignant liver tumors: current and emerging therapies. 3ª ed. New Jersey: John Wiley & Sons, 2010. p. 368-81. ISBN 978-1-4051-7976-8.

CARCINOMA HEPATOCELULAR; VIAS DE SINALIZACAO; TERAPIA MOLECULAR; CARCINOMA HEPATOCELULAR. PATOGENESE MOLECULAR; INIBIDORES DA TIROSINA QUINASE; INIBIDORES MTOR; INIBIDORES DA ANGIOGENESE


803/2682US=32 / Gastro
Cassileth BR, Gubili J. Integrative oncology: alternative and complementary treatments. In: Clavien PA, Breitenstein S. Malignant liver tumors: current and emerging therapies. 3ª ed. New Jersey: John Wiley & Sons, 2010. p. 414-20. ISBN 978-1-4051-7976-8.

ONCOLOGIA INTEGATIVA; MEDICINA ALTERNATIVA; TRATAMENTO FARMACOLOGICO; TRATAMENTO BIOLOGICO; DIETA; NUTRICAO; TERAPIAS METABOLICAS; DESINTOXICACAO; TRATAMENTO HERBAL; ACUPUNTURA; MUSICOTERAPIA; MASSAGEM TERAPEUTICA; TERAPIA MENTE-CORPO


804/2682US=25 / Mama
Schiff R, Osborne CK, Fuqua SAW. Clinical aspects of estrogen and progesterone receptors. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the breast. 4ªed. Philadelphia: Lippincott Williams & Wilkins, 2010. p. 408-30. ISBN 978-0-7817-9117-5.

RECEPTORES DE ESTROGENIO E PROGESTERONA; CANCER DE MAMA. RECEPTORES; TERAPIA ENDOCRINO


805/2682US=25 / Mama
Tham YL, Kramer R, Osborne CK. Evaluation of patients for metastasis prior to primary therapy. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the breast. 4ªed. Philadelphia: Lippincott Williams & Wilkins, 2010. p. 483-8. ISBN 978-0-7817-9117-5.

AVALIACAO DE PACIENTES; METASTASE ANTES DA TERAPIA PRIMARIA; CONTROLE DO CANCER; MARCADORES DE TUMORES


806/2682US=25 / Mama
Buchholz TA, Hunt KK. Breast-conserving therapy: conventional whole breast irradiation. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the breast. 4ªed. Philadelphia: Lippincott Williams & Wilkins, 2010. p. 507-21. ISBN 978-0-7817-9117-5.

TERAPIA CONSERVADORA DA MAMA; IRRADIACAO DA MAMA CONVENCIONAIS; CONSERVACAO DA MAMA NA MASTECTOMIA; TRATAMENTO COM RADIOTERAPIA


807/2682US=25 / Mama
Arthur DW, Vicini FA. Breast-conserving therapy: accelerated partial breast irradiation. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the breast. 4ªed. Philadelphia: Lippincott Williams & Wilkins, 2010. p. 522-8. ISBN 978-0-7817-9117-5.

TERAPIA CONSERVADORA DA MAMA; IRRADIACAO ACELERADA PARCIAL DA MAMA


808/2682US=25 / Mama
Morrow M, Harris JR. Local therapy for the breast and chest wall. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the breast. 4ªed. Philadelphia: Lippincott Williams & Wilkins, 2010. p. 540-1. ISBN 978-0-7817-9117-5.

TERAPIA LOCAL; TERAPIA DA MAMA; TERAPIA LOCAL DA PAREDE DO PEITO


809/2682US=25 / Mama
Rimawi MF, Osborne CK. Adjuvant systemic therapy: endocrine therapy. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the breast. 4ªed. Philadelphia: Lippincott Williams & Wilkins, 2010. p. 610-30. ISBN 978-0-7817-9117-5.

TERAPIA SISTEMICA ADJUVANTE; TERAPIA ENDOCRINA; TERAPIA ENDOCRINA; MODULADORES SELETIVOS DE RECEPTOR DE ESTROGENIO; ABLACAO OVARIANA ADJUVANTE; TOXICIDADE DE ABLACAO OVARIANA


810/2682US=25 / Mama
Mayer EL, Winer EP. Adjuvant systemic therapy: chemotherapy. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the breast. 4ªed. Philadelphia: Lippincott Williams & Wilkins, 2010. p. 631-44. ISBN 978-0-7817-9117-5.

TERAPIA SISTEMICA ADJUVANTE; QUIMIOTERAPIA


811/2682US=25 / Mama
Stearns V, Davidson NE. Adjuvant systemic therapy: chemoendocrine. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the breast. 4ªed. Philadelphia: Lippincott Williams & Wilkins, 2010. p. 645-56. ISBN 978-0-7817-9117-5.

TERAPIA SISTEMICA ADJUVANTE; QUIMIOTERAPIA ENDOCRINA; MANIPULACAO DO SISTEMA ENDOCRINO


812/2682US=25 / Mama
Gralow JR. Adjuvant systemic therapy: bisphosphonates. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the breast. 4ªed. Philadelphia: Lippincott Williams & Wilkins, 2010. p. 668-75. ISBN 978-0-7817-9117-5.

TERAPIA SISTEMICA ADJUVANTE; BISFOSFONATOS; TERAPIA ADJUVANTE EM ESTAGIOS INICIAIS; CANCER DE MAMA; CANCER DE MAMA. SAUDE OSSEA EM PACIENTES


813/2682US=25 / Mama
Aspitia AM, Perez EA. Side effects of systemic therapy: neurocognitive, cardiac, and secondary malignancies. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the breast. 4ªed. Philadelphia: Lippincott Williams & Wilkins, 2010. p. 692-704. ISBN 978-0-7817-9117-5.

TERAPIA SISTEMICA. EFEITOS COLATERAIS; NEUROCOGNITIVAS; CARDIACAS; NEOPLASIAS SECUNDARIAS; QUIMIOTERAPIA DEFICITS NEUROCOGNITIVOS; AGENTES ANTINEOPLASICOS; TERAPIA CANCER DE MAMA


814/2682US=25 / Mama
Flockhart DA, Rae JN. Pharmacogenomics of systemic therapy of breast câncer. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the breast. 4ªed. Philadelphia: Lippincott Williams & Wilkins, 2010. p. 705-710. ISBN 978-0-7817-9117-5.

FARMACOGENOMICA DA TERAPIA SISTEMICA. CANCER DE MAMA; FARMACOGENOMICA NO CANCER; FARMACOGENOMICA EM CANCER DE MAMA


815/2682US=25 / Mama
Davidson NE, Winer EP, Osborne CK. Guidelines for adjuvant systemic therapy. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the breast. 4ªed. Philadelphia: Lippincott Williams & Wilkins, 2010. p. 711-3. ISBN 978-0-7817-9117-5.

TERAPIA SISTEMICA ADJUVANTE; QUIMIOTERAPIA ADJUVANTE; TERAPIA ENDOCRINA ADJUVANTE


816/2682US=25 / Mama
Dang CT, Hudis C. Preoperative therapy for operable breast cancer. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the breast. 4ªed. Philadelphia: Lippincott Williams & Wilkins, 2010. p. 715-23. ISBN 978-0-7817-9117-5.

TERAPIA PRE-OPERATORIA. CANCER DE MAMA OPERAVEL; QUIMIOTERAPIA PRE-OPERATORIA


817/2682US=25 / Mama
Smith IE. Preoperative endocrine therapy for operable breast cancer. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the breast. 4ªed. Philadelphia: Lippincott Williams & Wilkins, 2010. p. 724-9. ISBN 978-0-7817-9117-5.

TERAPIA ENDOCRINA PRE-OPERATORIA. CANCER DE MAMA OPERAVEL


818/2682US=25 / Mama
Mamounas EP, Bellon JR. Local-regional therapy considerations in patients receiving preoperative chemotherapy. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the breast. 4ªed. Philadelphia: Lippincott Williams & Wilkins, 2010. p. 730-44. ISBN 978-0-7817-9117-5.

CANCER DE MAMA PRIMARIO; CANCER DE MAMA. TERAPIA EM PACIENTES QUE RECEBERAM QUIMIOTERAPIA PRE-OPERATORIA; BIOPSIA DO LINFONODO SENTINELA; TUMOR DE MAMA IPSILATERAL. RECORRENCIA; QUIMIOTERAPIA PRE-OPERATORIA


819/2682US=25 / Mama
Hortobagyi GN, Singletary JE, Strom EA. Locally advanced breast cancer. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the breast. 4ªed. Philadelphia: Lippincott Williams & Wilkins, 2010. p. 745-61. ISBN 978-0-7817-9117-5.

CANCER DE MAMA AVANCADO; CANCER DE MAMA. HISTORICO; TERAPIA ENDOCRINA NEOADJUVANTE; TERAPIA LOCAL; RADIOTERAPIA NO CANCER DE MAMA


820/2682US=25 / Mama
Merajver SD, Iniesta MD, Sabel MS. Inflammatory breast cancer. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the breast. 4ªed. Philadelphia: Lippincott Williams & Wilkins, 2010. p. 762-73. ISBN 978-0-7817-9117-5.

CANCER DE MAMA INFLAMATORIO; TERAPIA EM CANCER DE MAMA INFLAMATORIO


Primeira | Anterior | Próxima | Última